Abbvie Inc. - An Open-label extension of studies M15-736 and M20-339 to evaluate the safety and tolerability of 24-hour daily exposure of Abbv-951 in…
To investigate the association between variations in maternal effect genes and congenital anomalies, stillbirth, growth disorders, and intellectual…
Introduction:
The melanocortin-4 receptor (MC4R) pathway is the principal regulator of mammalian energy balance and body weight. Originating in the…
The purpose of the study is to evaluate the safety and efficacy of devices used in patients undergoing fetoscopic neural tube defect repair.
This is a prospective, multi-center, unblinded, randomized, controlled, and non-inferiority study comparing the EVA2 LVAS to the most recent…
This study is enrolling eligible patients who present to the Ben Taub Emergency Department with lower leg swelling caused by heart failure.
The goal…
RM-493-034: A 2-Stage (Open-Label Run-In Followed by Randomized Withdrawal), Double-Blind, Placebo-Controlled, Phase 2 Study of Setmelanotide In…
The study aims are to document the outcome of patients diagnosed prenatally with immune-mediated second or third degree AVB irrespective of the…
To provide home monitoring of fetal heart rate from 18-26 weeks and determine if treatment delivered <24 hours after onset of fetal heart block…
What is the purpose of this study?
The purpose of this study is to evaluate the effect of treatment with filgotinib on the induction and maintenance…